Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CVF

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$25M
Portfolio companies 4
Rounds per year 0.38
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Nanotechnology
  • Therapeutics
Summary

In 2005 was created CVF, which is appeared as Corporate Investor. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Davis.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Sonendo, Cerulean Pharma Among the most successful fund investment fields, there are Nanotechnology, Biotechnology.

The increased amount of exits for fund were in 2014. Speaking about the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2016. Opposing the other organizations, this CVF works on 9 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the CVF, startups are often financed by OrbiMed, Neomed Management, Fjord Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Venrock, Polaris Partners. In the next rounds fund is usually obtained by Venrock, Polaris Partners, OrbiMed.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CVF:
Typical Co-investors
CVF is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CVF:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arizona Founders Fund Arizona, Phoenix, United States
Authosis Ventures China, Hong Kong, Hong Kong Island
Bossa Ventures -
CCP Equity Partners Connecticut, Hartford, United States
China International Fund Management Co., Ltd -
Clal Finance Mutual Funds Ltd Israel, Tel Aviv, Tel Aviv District
Crescent Cove Advisors California, San Francisco, United States
Fullerton India India, Maharashtra, Mumbai
Hartnamtemah Inc. Canada, Ontario, Ottawa
IIM Calcutta Innovation Park India, Kolkata, West Bengal
RSA Capital Mequon, United States, Wisconsin
Scatec AS Norway, Oslo
Seibu Shinkin Bank Chiyoda, Japan
Spark Nova Scotia Canada, Halifax, Nova Scotia
Starbreeze Stockholm, Stockholm County, Sweden
Starwood VC Aspen, Colorado, United States
The Family -
TriTech Software Systems California, San Diego, United States
Zane Venture Fund Atlanta, Georgia, United States
Zino Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Genocea Biosciences

Biotechnology
Medical
$30M10 Oct 2012 Cambridge, Massachusetts, United States

Amnis

Analytics
Biotechnology
Genetics
Health Diagnostics
Manufacturing
Marketing
$11M29 Aug 2005 Seattle, Washington, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CVF?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 25M
Rounds per year 0.38
Peak activity year 2012
Lead investments 1
Follow on index 0.33
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Genocea Biosciences

Biotechnology
Medical
$30M10 Oct 2012 Cambridge, Massachusetts, United States

Amnis

Analytics
Biotechnology
Genetics
Health Diagnostics
Manufacturing
Marketing
$11M29 Aug 2005 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: